Scoparone ameliorates metabolic dysfunction-associated steatotic liver disease by regulating the miR-3073a-3p/CAMKK2 axis
Bibliographic Data
| ID | 14734103 |
|---|---|
| Authors | Kai Guo (0000-0001-9699-7527, Guilin Medical University), Houkang Cao (0000-0001-5496-6343, Guilin Medical University), Jianzhao Wu (Guilin Medical University), Wenxiu Wang (0000-0001-6490-9553), W H Wang (0000-0003-3858-9853, Guilin Medical University), Guiying Lu (Guilin Medical University), Riming Wei (0000-0001-7739-2557, Guilin Medical University), Tao Huang (0000-0003-0936-5033, Guilin Medical University), Yongwang Wang (Second Hospital of Tianjin Medical University, corresponding author), Ya Gao (0000-0002-4946-9235, Guilin Medical University, corresponding author), Kefeng Zhang (0000-0002-5303-3514, Guilin Medical University, corresponding author) |
| Year | 2026 |
| Volume | 365 |
| Pages | 121590 |
| Publication date | 2026-06-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Ethnopharmacology (JOURNAL) |
| Journal identifiers | ISSN: 0378-8741 • E-ISSN: 1872-7573 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.jep.2026.121590 |
| PMID | 41933743 |
| OpenAlex | W7147477088 |
| Language | EN |
| References cited | 34 |
By modifying the miR-3073a-3p/CAMKK2 axis, SCO improved MASLD, indicating its potential therapeutic utility in the management of metabolic liver disorders
Antioxidant · Autophagy · Fatty liver · Gene knockdown · In vivo · Lipid metabolism · Metabolic pathway · Nonalcoholic fatty liver disease · Signal transduction · Steatosis · Drug-Induced Hepatotoxicity and Protection · Liver Disease Diagnosis and Treatment · Liver physiology and pathology
| Citation velocity | historical |
|---|---|
| Highly cited | No |